InvestorsHub Logo
Followers 7
Posts 390
Boards Moderated 0
Alias Born 11/25/2020

Re: None

Friday, 09/03/2021 10:12:02 PM

Friday, September 03, 2021 10:12:02 PM

Post# of 63377
Remember: Lance is holding two Aces in his hand. An approved share offer to the mkt and an RS; the magic hand for cash generation through share dilution. Unfortunately, it seems to be the only way they can pay themselves millions AND fund a trial/ do a lab build out, etc.

Ideally, he will play the pair when they can get $20M from the sale whilst diluting shares no greater than 50%. I think a dilution greater than this attracts too much unwanted attention, of which they already have plenty.

I calculated that $.012 is the lowest share price that they could squeeze out $20M with a 50% dilution.

R/S of 1000 takes OS to 3.35M shares @ $12/share.

On its back, a share offer of an additional 3.35M shares at $6.00 each.

The R/S & Share offer could certainly be done at a lower share price to capture < $20M.

I would consider throwing a few $s at this after the squeeze and the stock is in oversold territory.

Still nothing on their exclusive rights expiring, which makes the BRTX-100 trial moot.

I really had hopes for this company, esp. Thermostem, but I don't see way they can get the cash necessary to gain any momentum w/o bending over current investors.

IMO






Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BRTX News